reviews of noom glp-1 medications are changing the conversation around weight and metabolism., It’s not just about willpower because biology plays a role. Programs like the Noom, GLP-1 Program combine medication with Noom GLP-1rx Plus Program —

GLP-1 users showed a 49% higher risk for vitamin D deficiency compared to people on SGLT2 inhibitors and a 32% higher risk compared to those on DPP-4 inhibitors

doi: 10.1210/jc.2016-2965 2 NederstigtCCorssmitEPde KoningEJDekkersOM

This heterogeneity complicates deriving a general estimate for HbA1c reduction with the combination compared to individual components, as greater effects are observed with more potent GLP1-RAs [30]

In a rodent model, a novel GLP-1R/GIPR/GCGR triple agonist, SAR441255, has been shown to promote weight loss and the maintenance of healthy blood glucose levels and is superior to the GLP-1R/GCGR dual agonist (Saxena et al., 2023)

This dual mechanism affects both its efficacy and its timing requirements

Discontinuation rates due to adverse events differ significantly: 7% for semaglutide versus 23% for Contrave in their respective important trials